Basit öğe kaydını göster

dc.contributor.authorKutlu, Pelin
dc.contributor.authorKarabulut, Seda
dc.contributor.authorKorkmaz, Oya
dc.date.accessioned2021-11-29T12:31:47Z
dc.date.available2021-11-29T12:31:47Z
dc.date.issued2021en_US
dc.identifier.citationKutlu, P., Karabulut, S. ve Korkmaz, O. (2021). Administration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile women. Clinical and Experimental Obstetrics and Gynecology, 48(5), 1025-1031. https://dx.doi.org/10.31083/j.ceog4805165en_US
dc.identifier.issn0390-6663
dc.identifier.issn2709-0094
dc.identifier.urihttps://dx.doi.org/10.31083/j.ceog4805165
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8588
dc.description.abstractObjective: There are diverse findings concerning the use of platelet-rich plasma (PRP) in assisted reproduction treatment (ART) cycles of infertile women with low ovarian reserve, ovarian failure or implantation failure due to endometrial problems. A debate continues regarding the benefit of this technique because of the low number of evidence-based studies. Mechanism: Different PRP preparation methods have been described in the literature, aiming to obtain the highest number of platelets following centrifugation steps. Findings in brief : Research on the use of PRP in female infertility aims to improve the deteriorated hormonal profile, gamete production and implantation of the embryo into the endometrium. Conclusions: This paper reviewed literature evaluating the impact of PRP on the outcomes of subsequent ART cycles in infertile women. PRP is a safe and easy-to-apply procedure and can be used as an 'add-on' therapy in patients with reduced ovarian reserve, ovarian failure or implantation failure prior to the in vitro fertilization (IVF) cycle, although it is still regarded as an empirical treatment method. Further studies should be conducted to enlighten the subject.en_US
dc.language.isoengen_US
dc.publisherIMR Pressen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectInfertilityen_US
dc.subjectIVFen_US
dc.subjectPlatelet-Rich Plasma (PRP)en_US
dc.subjectOvarian Failureen_US
dc.titleAdministration of autologous platelet rich plasma and the impact on outcomes of assisted reproduction treatment in infertile womenen_US
dc.typereviewen_US
dc.relation.ispartofClinical and Experimental Obstetrics and Gynecologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Histoloji ve Embriyoloji Ana Bilim Dalıen_US
dc.authorid0000-0003-3302-5004en_US
dc.authorid0000-0003-2923-5869en_US
dc.identifier.volume48en_US
dc.identifier.issue5en_US
dc.identifier.startpage1025en_US
dc.identifier.endpage1031en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.31083/j.ceog4805165en_US
dc.identifier.wosqualityQ4en_US
dc.identifier.scopusqualityQ4en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess